Commission Adopts Proposal For EU MDR Changes, Sets Out New Transition Deadlines

The European Commission is now a step closer to implementing legislation that will see staggered delays for the application of the MDR in a bid to forestall medical devices shortages across the EU, with even longer extensions proposed than previously expected.

The European Commission has today officially proposed to extend transition deadlines for compliance with the Medical Device Regulation. It follows an announcement on 9 December that confirmed action would be taken to ease pressure on the EU medtech regulatory system.

As anticipated, the commission is proposing new deadlines for compliance with the MDR that extend beyond the original deadline of...

More from Regulation

Where Do Questions Surrounding The EU’s AI Act Leave The Medtech Industry?

 

The EU’s Artificial Intelligence Act, which entered into force on 1 August 2024, is already facing turbulence.

Medtech Giants Brace for Tariffs Impact: Responses Range From Financial To Philosophical

 

Manufacturing shifts, financial planning, and supply chain changes are among the adjustments that medtech leaders are making to Trump-era tariffs. Medtech Insight’s review of first-quarter earnings calls reveals how firms are navigating the impact and uncertainty of evolving trade policies.

Final Curtain For LDTs? FDA Will Not Appeal District Court Decision To Vacate Final Rule

 

The US FDA has given up on its effort to regulate lab-developed tests as medical devices, at least for now. The agency will not appeal a decision from the Eastern District of Texas that tossed out the FDA’s final rule, leaving the agency with few cards.

EU Finalizes Framework For Joint Clinical Assessments Of High-Risk Devices

 

Second submission window for joint scientific consultations on a procedure to help prepare for joint clinical assessments will open from 2 to 30 June 2025.

More from Policy & Regulation